Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Shares Outstanding (2022 - 2025)

InMed Pharmaceuticals (INM) has 3 years of Shares Outstanding data on record, last reported at $700.0 in Q4 2023.

  • For Q4 2023, Shares Outstanding changed N/A year-over-year to $700.0; the TTM value through Dec 2023 reached $700.0, changed N/A, while the annual FY2023 figure was $3.3 million, 411.5% up from the prior year.
  • Shares Outstanding reached $700.0 in Q4 2023 per INM's latest filing, down from $3.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $3.3 million in Q2 2023 and bottomed at $700.0 in Q1 2023.
  • Average Shares Outstanding over 3 years is $1.1 million, with a median of $571354.0 recorded in 2022.
  • The widest YoY moves for Shares Outstanding: up 411.5% in 2023, down 99.88% in 2023.
  • A 3-year view of Shares Outstanding shows it stood at $14.1 million in 2021, then tumbled by 93.57% to $908766.0 in 2022, then tumbled by 99.92% to $700.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $700.0 in Q4 2023, $3.3 million in Q3 2023, and $3.3 million in Q2 2023.